(Q39866142)

15 September 2017

title

A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo (English)

1 reference

15 September 2017

Eva J Koziolek

2

0 references

Terrance G Johns

object named as

Terrance G Johns

14

0 references

Timothy E Adams

object named as

Timothy E Adams

1

0 references

Andrew M Scott

object named as

Andrew M Scott

9

0 references

author name string

Peter H Hoyne

3

1 reference

15 September 2017

John D Bentley

4

1 reference

15 September 2017

Louis Lu

5

1 reference

15 September 2017

George Lovrecz

6

1 reference

15 September 2017

Colin W Ward

7

1 reference

15 September 2017

F T Lee

8

1 reference

15 September 2017

Andrew D Nash

10

1 reference

15 September 2017

Julie Rothacker

11

1 reference

15 September 2017

Edouard C Nice

12

1 reference

15 September 2017

Antony W Burgess

13

1 reference

15 September 2017

publication date

1 June 2009

1 reference

15 September 2017

published in

Growth Factors Journal

1 reference

15 September 2017

volume

27

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

141-154

1 reference

Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Monoclonal antibodies targeting the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Gefitinib-trastuzumab combination on hormone-refractory prostate cancer xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

VEGF-Trap: a VEGF blocker with potent antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Instrumental biosensors: new perspectives for the analysis of biomolecular interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Validation of HB-EGF and amphiregulin as targets for human cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190902843565

10.1080/08977190902843565

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference